Biotechnology Advances (BA) is a scholarly journal dedicated to publishing research in the field of Immunology and Microbiology. Elsevier is the publisher of this esteemed journal. The P-ISSN assigned to Biotechnology Advances is 0734-9750 and its abbreviated form is Biotechnol Adv.
Biotechnology Advances is a review journal which considers all aspects of the multidisciplinary field. The scope includes biotechnology principles and applications in industry, agriculture, medicine, environmental concerns and regulatory issues. Authoritative articles on current developments and future trends in biotechnology are empathized. Submissions of appropriate manuscripts are invited. A wide audience of scientists, engineers and others is addressed: students, instructors, researchers, practitioners, managers, governments and related stakeholders. Special issues are published on selections of presentations at recent relevant conferences as arranged with the organizations.
|Journal title||Biotechnology Advances (BA)|
|Editor-in-chief||Professor Edward A. Bayer|
|Subject Category||Immunology and Microbiology|
Biotechnology Advances Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Biotechnology Advances Journal is Biotechnol Adv.
The Ranking of Biotechnology Advances in 2023 is 795. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of Biotechnology Advances in 2023 is 16. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of Biotechnology Advances in 2023 is 2.629. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Acceptance Rate of Biotechnology Advances in 2023 is 16%. It is a measure that provides insight into the selectivity and competitiveness of a journal's editorial process.
The H-Index of Biotechnology Advances in 2023 is 226. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of Biotechnology Advances is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Biotechnology Advances is indexed in (Indexing details)
|PubMed||Scopus||Web of Science||UGC||Embase||DOAJ|
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
The Editor-in-chief of Biotechnology Advances is Professor Edward A. Bayer
Biotechnology Advances Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of Biotechnology Advances is $5300
Biotechnology Advances Call for paper : Biotechnology Advances invites original research contributions for consideration of publication in Biotechnology Advances journal.
Journal seeking submissions in the broad areas of Immunology and Microbiology that align with journal's focus on Immunology and Microbiology.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Biotechnology Advances involves the following steps:
Yes, the Biotechnology Advances journal is indexed in PubMed.
Yes, the Biotechnology Advances journal is indexed in Scopus.
Yes, the Biotechnology Advances journal is indexed in UGC.
No, the Biotechnology Advances journal is not indexed in Index copernicus.
No, Biotechnology Advances journal is not a predatory journal.
The Impact Factor of the Biotechnology Advances is 16.
The Ranking of the Biotechnology Advances is 795.
Yes the Biotechnology Advances (BA) journal is a peer-reviewed journal.
Yes the Biotechnology Advances journal is a peer-reviewed journal and good to publish your paper.
Yes, Biotechnology Advances is a open access (Hybrid) journal.